FDA
approval
· 2022-05-20
FDA Approved: EXEMESTANE — Original Application (Aurobindo Pharma Limited)
Summary
The FDA approved the original ANDA for Exemestane from Aurobindo Pharma Limited, establishing a generic aromatase inhibitor. It relates to treatment of breast c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EXEMESTANE (EXEMESTANE)